Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Schering researchers describe new histamine H3 antagonists and their use

Nov. 28, 2003

ELITE trial studies TOBI for early-onset P. aeruginosa in cystic fibrosis

Nov. 28, 2003

Yissum presents multifunctional agents for asthma and other respiratory diseases

Nov. 27, 2003

Positive trends in improvement of FEV1 in phase II trial of DCF-987

Nov. 27, 2003

Novel chemokine CCR3 antagonists prepared and tested at Teijin

Nov. 26, 2003

Boehringer Ingelheim presents new muscarinic M3 antagonists

Nov. 25, 2003

Medivir and Hengrui to develop protease inhibitor drugs for COPD

Nov. 25, 2003

Novel antihistaminic agents prepared and tested at Sun Pharmaceutical

Nov. 21, 2003

Advair Diskus receives FDA approval

Nov. 20, 2003

Almirall Prodesfarma presents new muscarinic M3 antagonists in a recent patent

Nov. 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...